Keynote speaker and prize ceremony
Plenary Session I:
Screening for thrombophilia and pregnancy complications
Parallel Session II:
Parallel Session III:
Epidemiology and risk factors of venous thrombosis in children
Plenary Session IV:
Parallel Session V:
Parallel Session VI:
Replacement therapy before surgery of FVII & FXI deficient patients
Industry SymposiumSession not included in main CME/CPD credit programFor more information, click here
Parallel Session VII:
Pharmacogenomics; Thrombolytic therapy
Parallel Session VIII:
Heparins, warfarin and new anticoagulants for pediatric venous thrombosis
Plenary Session IX:
Immune thrombocytopenia; Bleeding complications of new oral anticoagulants
Parallel Session X:
Primary prevention of venous thrombosis and coronary artery disease
Parallel Session XI:
Plasma derived versus recombinant factor VIII concentrates
Thrombotic disorders and anti-thrombotics
Bleeding disorders
Pediatrics
Industry session